[PDF] Top 20 平成14年3月期 第2四半期 中間決算短信(連結) 決算短信 | IRライブラリー | 株主・投資家の皆様へ | アマノ
Has 10000 "平成14年3月期 第2四半期 中間決算短信(連結) 決算短信 | IRライブラリー | 株主・投資家の皆様へ | アマノ" found on our website. Below are the top 20 most common "平成14年3月期 第2四半期 中間決算短信(連結) 決算短信 | IRライブラリー | 株主・投資家の皆様へ | アマノ".
The antiplatelet activity of Escherichia coli lipopolysaccharide is mediated through a nitric oxide/cyclic GMP pathway.
... In this study, Escherichia coli LPS dose-dependently (100-500 μg/ ml) and time- dependently (10-60 min) inhibited platelet aggregation in human and rabbit platelets stimulated by agonis[r] ... 完全なドキュメントを参照
The antiplatelet activity of escherichia coli lipopolysaccharide is mediated through a nitric oxide/cyclic GMP pathway.
... study, Escherichia coli LPS dose-dependently (100-500 microg/ml) and time-dependently (10-60 min) inhibited platelet aggregation in human and rabbit platelets stimulated by ...inhibited the ... 完全なドキュメントを参照
2
The Antiplatelet activity of ketamine is mediated through suppression of phosphoinositide breakdown and an increase in cyclic GMP.
... coli LPS may be involved in the activation of a nitric oxide/cyclic GMP pathway in platelets, resulting in inhibition of platelet aggregation. Therefore, LPS-mediated alteration of pla[r] ... 完全なドキュメントを参照
The Antiplatelet activity of ketamine is mediated through suppression of phosphoinositide breakdown and an increase in cyclic GMP.
... In this study, Escherichia coli LPS dose-dependently (100-500 μg/ ml) and time- dependently (10-60 min) inhibited platelet aggregation in human and rabbit platelets stimulated by agonis[r] ... 完全なドキュメントを参照
Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.
... The present study reports a novel and potent antiplatelet agent, CAPE, which involved in the following inhibitory pathways: CAPE increases cyclic GMP/VASP Ser157 phosphorylation, and s[r] ... 完全なドキュメントを参照
3
Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway
... In this study, Gram-positive Staphylococcus aureus lipoteichoic acid (LTA) dose dependently (0.1-1.0 microg/mL) and time dependently (10-60 min) inhibited platelet aggregation in human[r] ... 完全なドキュメントを参照
2
Antiplatelet activity of staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway
... Sheu JR;Hsiao G;Lee CR;Chang WC;Lee LW;Su CH and Lin CH Abstract In this study, Gram-positive Staphylococcus aureus ence Ltd. All rights reserved. lipoteichoic acid (LTA) dose dependently (0.1–1.0 mg/mL) and time ... 完全なドキュメントを参照
Antiplatelet activity of staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway
... gation; Cyclic AMP; Protein kinase C lated by agonists ...as a consequence of Ca21 mobilization in human platelets stimulated Gram-negative bacteraemia, septic shock by ... 完全なドキュメントを参照
Antiplatelet Activity of Staphylococcus aureus Lipoteichoic Acid Is Mediated Through a Cyclic AMP Pathway
... In this study, Gram-positive Staphylococcus aureus lipoteichoic acid (LTA) dose dependently (0.1-1.0 microg/mL) and time dependently (10-60 min) inhibited platelet aggregation in human[r] ... 完全なドキュメントを参照
9
α-Naphthoflavone, a Potent Antiplatelet Flavonoid, Is Mediated through Inhibition of Phospholipase C Activity and Stimulation of Cyclic GMP Formation
... (1) α-NF may inhibit the activation of phospholipase C, followed by inhibition of phosphoinositide breakdown, protein kinase C activation, and thromboxane A2 formation, thereby leading[r] ... 完全なドキュメントを参照
4
alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
... (1) alpha-NF may inhibit the activation of phospholipase C, followed by inhibition of phosphoinositide breakdown, protein kinase C activation, and thromboxane A(2) formation, thereby l[r] ... 完全なドキュメントを参照
2
Alpha-naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
... alpha-NF (5 and 10 microM) inhibited intracellular Ca(2+) mobilization, phosphoinositide breakdown, and thromboxane A(2) formation stimulated by collagen (1 microg/mL) in human platele[r] ... 完全なドキュメントを参照
Alpha-naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
... (1) alpha-NF may inhibit the activation of phospholipase C, followed by inhibition of phosphoinositide breakdown, protein kinase C activation, and thromboxane A(2) formation, thereby l[r] ... 完全なドキュメントを参照
The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase.
... Furthermore, TMPZ concentration (50 and 200m M)- and time (15 and 30 min)-dependently triggered endothelial- type constitutive nitric oxide synthase (ecNOS) protein expr[r] ... 完全なドキュメントを参照
The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase.
... Furthermore, TMPZ concentration (50 and 200m M)- and time (15 and 30 min)-dependently triggered endothelial- type constitutive nitric oxide synthase (ecNOS) protein expression in huma[r] ... 完全なドキュメントを参照
Fluvastatin Reduces Pulmonary Vein Spontaneous Activity Through Nitric Oxide Pathway
... before the fluvastatin administration. which further suggested that the mechanoelectrical feedback through the nitric oxide-cGMP pathway played a key role in ... 完全なドキュメントを参照
Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway
... administration of fluvastatin in rabbit PVs or atria. Results: Fluvastatin decreased the PV spontaneous activity, diastolic tension, and contractility, but did not change the action potential ... 完全なドキュメントを参照
The antiplatelet activity of PMC, a potent a-tocopherol analogue, is mediated through inhibition of cyclooxygenase. Br.
... inhibited the intracellular Ca2+ mobilization, whereas it did not inhibit phosphoinositide breakdown in human platelets stimulated by ...thromboxane A2 (TxA2) formation in human platelets. On the ... 完全なドキュメントを参照
The antiplatelet activity of PMC, a potent a-tocopherol analogue, is mediated through inhibition of cyclooxygenase. Br.
... inhibited the intracellular Ca2+ mobilization, whereas it did not inhibit phosphoinositide breakdown in human platelets stimulated by ...thromboxane A2 (TxA2) formation in human platelets. On the ... 完全なドキュメントを参照
The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.
... to the inhiother hand, rutaecarpine (50 and 100 mM) dose- bition of phospholipase C activity, leading to redependently inhibited the increase in intracellular duce phosphoinositide breakdown, ... 完全なドキュメントを参照
関連した話題